Apr 21, 20233 minApabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in BiomedicinesPreviously Announced Findings to Appear in the High-Impact Scientific Journal
Apr 21, 20233 minRakovina Therapeutics Inc. Receives European and Canadian Patents on kt-2000 series PARP-inhibitorsLead candidates from Rakovina Therapeutics' kt-2000 series exhibit potency comparable to FDA-approved PARP-inhibitors and potent anti-cancer
Apr 21, 20234 minHEALTH | BIOTECHNOLOGYBeyond Medical Manufactures N95 Medical Face Masks as Third Wave of COVID-19 SurgesMicron Technologies has submitted its N95 Model 8800 face masks to NIOSH and is confident it will obtain NIOSH certification...
Apr 21, 20233 minHEALTH | BIOTECHNOLOGYRakovina Therapeutics Inc. Commences Trading on TSX Venture Exchange Under Ticker Symbol "RKV"The company will focus on the development of novel DNA-damage repair (DDR) inhibitors for the treatment of cancer